• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Increasing evidence for the efficacy of hepatic arterial infusion chemotherapy combined with systemic therapy for advanced hepatocellular carcinoma with macrovascular invasion: time to consider a more effective approach.肝动脉灌注化疗联合全身治疗对伴有大血管侵犯的晚期肝细胞癌疗效的证据不断增加：是时候考虑一种更有效的方法了。
J Gastrointest Oncol. 2023 Oct 31;14(5):2282-2286. doi: 10.21037/jgo-23-760. Epub 2023 Oct 10.
2
Hepatic arterial infusion chemotherapy and immune checkpoint inhibitors, alone or in combination, in advanced hepatocellular carcinoma with macrovascular invasion: a single-centre experience in Taiwan.肝动脉灌注化疗与免疫检查点抑制剂单独或联合用于伴大血管侵犯的晚期肝细胞癌：台湾地区单中心经验
J Gastrointest Oncol. 2023 Apr 29;14(2):849-862. doi: 10.21037/jgo-22-858. Epub 2023 Apr 10.
3
Pathological complete response by advanced hepatocellular carcinoma with massive macrovascular invasion to hepatic arterial infusion chemotherapy: a case report.巨块型大血管侵犯的晚期肝细胞癌经肝动脉灌注化疗达到病理完全缓解：1 例报告。
World J Surg Oncol. 2019 Dec 26;17(1):229. doi: 10.1186/s12957-019-1772-8.
4
Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status.比较有大血管侵犯和经导管动脉化疗栓塞耐药状态的晚期肝细胞癌患者行肝动脉灌注化疗和索拉非尼治疗的临床结局。
J Gastroenterol Hepatol. 2018 Oct;33(10):1780-1786. doi: 10.1111/jgh.14152. Epub 2018 May 10.
5
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity.化疗多样化时代的晚期肝细胞癌肝动脉灌注化疗。
Clin Mol Hepatol. 2023 Jul;29(3):593-604. doi: 10.3350/cmh.2022.0391. Epub 2023 Feb 13.
6
Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma.肝动脉灌注化疗与索拉非尼治疗晚期肝细胞癌的疗效比较
Liver Cancer. 2020 Sep;9(5):583-595. doi: 10.1159/000508724. Epub 2020 Jul 24.
7
Postprogression treatment of lenvatinib plus PD-1 inhibitor in advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy.仑伐替尼联合 PD-1 抑制剂治疗经肝动脉化疗栓塞治疗失败的晚期肝细胞癌的后线治疗。
Cancer. 2023 Jul 15;129(14):2235-2244. doi: 10.1002/cncr.34764. Epub 2023 Apr 7.
8
Comparative safety and efficacy of molecular-targeted drugs, immune checkpoint inhibitors, hepatic arterial infusion chemotherapy and their combinations in advanced hepatocellular carcinoma: findings from advances in landmark trials.分子靶向药物、免疫检查点抑制剂、肝动脉灌注化疗及其联合疗法在晚期肝细胞癌中的安全性和疗效比较：标志性试验进展的研究结果
Front Biosci (Landmark Ed). 2021 Oct 30;26(10):873-881. doi: 10.52586/4994.
9
Development and validation of prognostic nomograms for large hepatocellular carcinoma after HAIC.经肝动脉灌注化疗后大肝癌预后列线图的构建与验证
Ther Adv Med Oncol. 2023 Apr 17;15:17588359231163845. doi: 10.1177/17588359231163845. eCollection 2023.
10
Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis.肝动脉灌注化疗诱导治疗可提高乐伐替尼和PD1抑制剂治疗门静脉肿瘤血栓形成的肝细胞癌患者的疗效。
J Gastroenterol. 2023 Apr;58(4):413-424. doi: 10.1007/s00535-023-01976-x. Epub 2023 Mar 9.

本文引用的文献

1
Cisplatin in Liver Cancer Therapy.顺铂在肝癌治疗中的应用。
Int J Mol Sci. 2023 Jun 29;24(13):10858. doi: 10.3390/ijms241310858.
2
Hepatic arterial infusion chemotherapy and immune checkpoint inhibitors, alone or in combination, in advanced hepatocellular carcinoma with macrovascular invasion: a single-centre experience in Taiwan.肝动脉灌注化疗与免疫检查点抑制剂单独或联合用于伴大血管侵犯的晚期肝细胞癌：台湾地区单中心经验
J Gastrointest Oncol. 2023 Apr 29;14(2):849-862. doi: 10.21037/jgo-22-858. Epub 2023 Apr 10.
3
Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis.肝动脉灌注化疗诱导治疗可提高乐伐替尼和PD1抑制剂治疗门静脉肿瘤血栓形成的肝细胞癌患者的疗效。
J Gastroenterol. 2023 Apr;58(4):413-424. doi: 10.1007/s00535-023-01976-x. Epub 2023 Mar 9.
4
Sorafenib plus hepatic arterial infusion chemotherapy versus sorafenib alone for advanced hepatocellular carcinoma: A systematic review and meta-analysis.索拉非尼联合肝动脉化疗栓塞与索拉非尼单药治疗晚期肝细胞癌的系统评价和荟萃分析。
J Gastroenterol Hepatol. 2023 Apr;38(4):486-495. doi: 10.1111/jgh.16088. Epub 2023 Jan 16.
5
Comparative effectiveness of interventional therapeutic modalities for unresectable hepatocellular carcinoma: A systematic review and network meta-analysis.不可切除肝细胞癌介入治疗方式的比较有效性：一项系统评价和网状Meta分析。
Oncol Lett. 2022 Aug 31;24(4):366. doi: 10.3892/ol.2022.13486. eCollection 2022 Oct.
6
Efficacy and safety of atezolizumab plus bevacizumab combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma.阿替利珠单抗联合贝伐珠单抗联合肝动脉灌注化疗治疗晚期肝细胞癌的疗效和安全性。
Front Immunol. 2022 Aug 5;13:929141. doi: 10.3389/fimmu.2022.929141. eCollection 2022.
7
Efficacy and Safety of Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma and Child-Pugh Class B: A Retrospective Cohort Study.动脉灌注化疗治疗中晚期乙型肝炎肝硬化肝癌患者的疗效及安全性：一项回顾性队列研究。
Oncology. 2022;100(5):278-289. doi: 10.1159/000523703. Epub 2022 Feb 18.
8
Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative review.肝细胞癌合并门静脉癌栓患者的管理：一篇叙述性综述。
Hepatobiliary Pancreat Dis Int. 2022 Apr;21(2):134-144. doi: 10.1016/j.hbpd.2021.12.004. Epub 2021 Dec 16.
9
Arterial Chemotherapy of Oxaliplatin Plus Fluorouracil Versus Sorafenib in Advanced Hepatocellular Carcinoma: A Biomolecular Exploratory, Randomized, Phase III Trial (FOHAIC-1).奥沙利铂联合氟尿嘧啶与索拉非尼治疗晚期肝细胞癌的动脉化疗：一项生物分子探索性、随机、III 期试验（FOHAIC-1）。
J Clin Oncol. 2022 Feb 10;40(5):468-480. doi: 10.1200/JCO.21.01963. Epub 2021 Dec 14.
10
Hepatocellular Carcinoma in 2021: An Exhaustive Update.2021年肝细胞癌：详尽的最新进展
Cureus. 2021 Nov 5;13(11):e19274. doi: 10.7759/cureus.19274. eCollection 2021 Nov.

Increasing evidence for the efficacy of hepatic arterial infusion chemotherapy combined with systemic therapy for advanced hepatocellular carcinoma with macrovascular invasion: time to consider a more effective approach.

作者信息

Moriya Kei, Nagamatsu Shinsaku, Uejima Masakazu, Matsuo Hideki

机构信息

Department of Gastroenterology, Nara Prefecture General Medical Center, Nara, Japan.

Department of Gastroenterology and Hepatology, Nara Medical University, Kashihara, Japan.

出版信息

J Gastrointest Oncol. 2023 Oct 31;14(5):2282-2286. doi: 10.21037/jgo-23-760. Epub 2023 Oct 10.

DOI:10.21037/jgo-23-760
PMID:37969841
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10643572/
Abstract
摘要